ALS Research
With your support, The ALS Association’s TREAT ALS™ research program fuels global collaboration to expedite the discovery of treatments and a cure for amyotrophic lateral sclerosis (ALS).
The Premier ALS Research Program in the World
Everything we do supports our mission of finding treatments and a cure for ALS, which is why it is so critical to fund outstanding ALS research. We have the premier ALS research program in the world.
Our approach is simple and has led to some of the biggest research discoveries in the history of ALS. We fund the best, most promising research around the globe, while inspiring... and initiating innovative partnerships across all sectors – government, industry, academia, and other nonprofit organizations – while funding bright, young scientists to spur innovation.
Thanks to the donations raised during the ALS Ice Bucket Challenge, we are now spending three times more than on ALS research than before summer 2014.
Some of the things we're working on:
- 3 potential new ALS antisense drugs
- Key advances in wearable sensor and brain computer interface technology
- New treatment approaches in clinical trials
- Research Discoveries
159+
Funded Global Research Projects in 10 Countries
$18M
Current Research Budget
(Highest nonprofit research funder in the U.S.)
Latest Research Breakthrough
On April 25, 2023, the FDA approved a new ALS treatment drug called Tofersen. Tofersen is the first gene-based therapy for ALS to be approved, and marks a promising advancement in Antisense technology.
Lawrence and Isabel Barnett Drug Development Program
Our Lawrence and Isabel Barnett Drug Development Program allows us the freedom to strategically fund preclinical projects aimed at developing therapeutics for ALS that are product-driven.
Annual Research Symposium
Every year, the Chapter hosts a Research Symposium featuring discussion about the latest in ALS research. The event features live presentations from local and nationally esteemed ALS researchers and clinicians.
With The ALS Association’s ongoing support, my work in antisense technology, which was once thought of as innovative and risky, has led to clinical trials that could help people with ALS and other neurodegenerative diseases."
Don Cleveland, Ph.D.
University of California at San Diego
National ALS Registry
The National ALS Registry may be the single largest ALS research project ever created and is designed to identify ALS cases from throughout the entire United States.
You Are Part of the Solution
Your gift will help The ALS Association support research to find treatments and a cure for ALS.